Category: Pharma News

एक अभिनव Stem Cell Robot जिसका UK MHR परीक्षण कर रहा है, जीवन रक्षक सेल उपचारों की पहुंच में क्रांति ला सकता है

The UK Medicines and Healthcare products Regulatory Agency is testing the CellQualia Intelligent Cell Processing System, a novel robotic robot that cultivates stem cells (MHRA). This robotic technology has the potential to offer patients with a variety of ailments safer…

Merck gives an update from the phase 2 KeyVibe-002 trial of MK-7684A, a coformulation of vibostolimab with pembrolizumab, in patients with metastatic NSCLC who have already received treatment.

The open-label portion of the non-registrational phase 2 KeyVibe-002 trial received an update from Merck, also known as MSD outside of the United States and Canada. For the treatment of patients with metastatic non-small cell lung cancer (NSCLC) who have…

Oxford Nanopore and Cyclomics start testing a non-invasive technique for the rapid and precise detection of compounds linked to cancer.

Netherlands startup and Oxford Nanopore Technologies The world’s first nanopore sequencing-based technology for ultra-sensitive detection of circulating tumour DNA has been made available to developers by Cyclomics (ctDNA). The procedure finds and evaluates cell-free DNA (cfDNA) in the blood. As…

Phase-II of the ATH434 trial for multiple system atrophy patient dosing has started, according to Alterity Therapeutics.

The first participant in Alterity Therapeutics’ phase 2 clinical trial of ATH434 in multiple system atrophy (MSA), a rare and severely handicapping Parkinson’s disease, has been dosed in the US, according to the biotechnology company’s announcement. Alterity Therapeutics is dedicated…

Back to top
WhatsApp Join Telegram